Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Plymouth Meeting, Pennsylvania
- Most recent report
- 8-K, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1055726
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 74
News 8 of 167
Prospectuses and Registrations 8 of 90
- 424B5 Prospectus supplement for an offering Nov 6, 2026
- FWP Free writing prospectus Nov 6, 2026
- 424B5 Prospectus supplement for an offering Nov 5, 2026
- 424B5 Prospectus supplement for an offering Jul 30, 2026
- 424B5 Prospectus supplement for an offering Jul 29, 2026
- S-3 Shelf registration statement Jul 2, 2026
- S-8 Registration statement for an employee plan May 26, 2026
- 424B5 Prospectus supplement for an offering Apr 2, 2026
Proxies 8 of 27
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2024
- DEF 14A Proxy statement for a shareholder vote Nov 28, 2023
- PRE 14A Preliminary proxy statement Nov 17, 2023
- DEFA14A Extra proxy material Mar 31, 2023
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2023
- DEFA14A Extra proxy material May 11, 2022
Ownership 8 of 574
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
Other 8 of 69
- EFFECT Notice that a registration became effective Jul 10, 2026
- ARS Annual report sent to shareholders Apr 7, 2025
- ARS Annual report sent to shareholders Apr 15, 2024
- EFFECT Notice that a registration became effective Jan 31, 2024
- CORRESP Reply to SEC staff Jan 29, 2024
- UPLOAD Comment letter from SEC staff Nov 16, 2023
- EFFECT Notice that a registration became effective Apr 3, 2023
- ARS Annual report sent to shareholders Mar 28, 2023
Everything here comes from Inovio Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.